Literature DB >> 33230593

The extracellular lactate-to-pyruvate ratio modulates the sensitivity to oxidative stress-induced apoptosis via the cytosolic NADH/NAD+ redox state.

Simei Go1,2, Thorquil T Kramer1,2, Arthur J Verhoeven1,2, Ronald P J Oude Elferink1,2, Jung-Chin Chang3,4.   

Abstract

The advantages of the Warburg effect on tumor growth and progression are well recognized. However, the relevance of the Warburg effect for the inherent resistance to apoptosis of cancer cells has received much less attention. Here, we show here that the Warburg effect modulates the extracellular lactate-to-pyruvate ratio, which profoundly regulates the sensitivity towards apoptosis induced by oxidative stress in several cell lines. To induce oxidative stress, we used the rapid apoptosis inducer Raptinal. We observed that medium conditioned by HepG2 cells has a high lactate-to-pyruvate ratio and confers resistance to Raptinal-induced apoptosis. In addition, imposing a high extracellular lactate-to-pyruvate ratio in media reduces the cytosolic NADH/NAD+ redox state and protects against Raptinal-induced apoptosis. Conversely, a low extracellular lactate-to-pyruvate ratio oxidizes the cytosolic NADH/NAD+ redox state and sensitizes HepG2 cells to oxidative stress-induced apoptosis. Mechanistically, a high extracellular lactate-to-pyruvate ratio decreases the activation of JNK and Bax under oxidative stress, thereby inhibiting the intrinsic apoptotic pathway. Our observations demonstrate that the Warburg effect of cancer cells generates an anti-apoptotic extracellular environment by elevating the extracellular lactate-to-pyruvate ratio which desensitizes cancer cells towards apoptotic insults. Consequently, our study suggests that the Warburg effect can be targeted to reverse the lactate-to-pyruvate ratios in the tumor microenvironment and thereby re-sensitize cancer cells to oxidative stress-inducing therapies.

Entities:  

Keywords:  Cytosolic NADH/NAD+ redox state; JNK; Lactate; Pyruvate; Raptinal; Warburg effect

Mesh:

Substances:

Year:  2020        PMID: 33230593      PMCID: PMC7902596          DOI: 10.1007/s10495-020-01648-8

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  37 in total

1.  A cytological study of colchicine-induced chimeras in Haplopappus gracilus A. Gray.

Authors:  M S Zakaryan
Journal:  Sov Genet       Date:  1973-12-01

Review 2.  Oncogenic alterations of metabolism.

Authors:  C V Dang; G L Semenza
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

Review 3.  Reactive oxygen species in tumor progression.

Authors:  Peter Storz
Journal:  Front Biosci       Date:  2005-05-01

Review 4.  HIF-1 and tumor progression: pathophysiology and therapeutics.

Authors:  Gregg L Semenza
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

Review 5.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

6.  Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor.

Authors:  Chang Xia; Qiao Meng; Ling-Zhi Liu; Yongyut Rojanasakul; Xin-Ru Wang; Bing-Hua Jiang
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 7.  The pentose phosphate pathway and cancer.

Authors:  Krushna C Patra; Nissim Hay
Journal:  Trends Biochem Sci       Date:  2014-07-15       Impact factor: 13.807

Review 8.  Persistent oxidative stress in cancer.

Authors:  S Toyokuni; K Okamoto; J Yodoi; H Hiai
Journal:  FEBS Lett       Date:  1995-01-16       Impact factor: 4.124

Review 9.  Reactive oxygen species in tumorigenesis.

Authors:  D I Feig; T M Reid; L A Loeb
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

Review 10.  Combination therapy in combating cancer.

Authors:  Reza Bayat Mokhtari; Tina S Homayouni; Narges Baluch; Evgeniya Morgatskaya; Sushil Kumar; Bikul Das; Herman Yeger
Journal:  Oncotarget       Date:  2017-06-06
View more
  4 in total

1.  Cross-comparison of systemic and tissue-specific metabolomes in a mouse model of Leigh syndrome.

Authors:  Karin Terburgh; Jeremie Z Lindeque; Francois H van der Westhuizen; Roan Louw
Journal:  Metabolomics       Date:  2021-11-18       Impact factor: 4.290

2.  PUFA Treatment Affects C2C12 Myocyte Differentiation, Myogenesis Related Genes and Energy Metabolism.

Authors:  Marua Abu Risha; Puntita Siengdee; Dirk Dannenberger; Klaus Wimmers; Siriluck Ponsuksili
Journal:  Genes (Basel)       Date:  2021-01-28       Impact factor: 4.096

Review 3.  The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer.

Authors:  Junjie Zhao; Lixia Xu; Zihui Dong; Yize Zhang; Junhua Cao; Jie Yao; Jiyuan Xing
Journal:  Front Cell Dev Biol       Date:  2022-02-03

Review 4.  Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases.

Authors:  Qinfan Yao; Xiuyuan Zhang; Dajin Chen
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.